Felix Pharma SA
Felix Pharma reported total assets of 560,983 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of Felix Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Felix Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 26 Jul 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 30 Jun 2021filed on 15 Nov 2021
Felix Pharma's financial analysis
- Solvency99.9%sector median: 20.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Felix Pharma
Felix Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0477.939.091
- VAT number
- BE0477939091
- Peppol
- Registered · 0208:0477939091 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 09 Jul 2002
- Registered office
- 7080 Frameries
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Buying and selling of own real estate (NACE 68110)
Felix Pharma (SA) has been based in Frameries since 2002, active in: buying and selling of own real estate. For 2025, it reports a net profit of 201 € and equity of 560,583 €; its revenue is not published. Its solvency stands at 99.9%, above the median of its sector (20.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Felix Pharma
Companies in the same business, of comparable size and area, outside its group.
- Cybe Investments Financial service activities, except insurance and pension funding Sint-Martens-Latem · balance sheet 561,074 €
- FID Invest Activities of holding companies Juprelle · balance sheet 561,090 €
- Epahol Activities of holding companies Ixelles · balance sheet 560,702 €
- Gelim Brussels · balance sheet 561,355 €
- Assure Finance Beethoven Computing infrastructure, data processing, hosting and related activities Incourt · balance sheet 560,112 €
- G.E. Invest Activities of head offices Aalst · balance sheet 562,249 €
- Asfalt Invest Knokke-Heist · balance sheet 559,614 €
- B2Boost Management Invest Activities of holding companies Wavre · balance sheet 562,417 €
Frequently asked questions about Felix Pharma
What is the revenue of Felix Pharma?
Felix Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Felix Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0477939091 for Felix Pharma, if the company is VAT-registered. Its company number (CBE) is 0477.939.091.
Where is the registered office of Felix Pharma?
According to the CBE register, the registered office of Felix Pharma is in 7080 Frameries.
What is the equity of Felix Pharma?
At the close of the 2025 financial year, the equity of Felix Pharma amounts to 560,583 €, a solvency of 99.9% of total assets.
Who manages Felix Pharma?
The register lists 6 active mandates at Felix Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Felix Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →